Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2008; 52:734-739, doi:10.1016/j.jacc.2008.05.032
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View CVN News Brief
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gori, A. M.
Right arrow Articles by Antoniucci, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Gori, A. M.
Right arrow Articles by Antoniucci, D.
Related Collections
Right arrowRelated Articles

Incidence and Clinical Impact of Dual Nonresponsiveness to Aspirin and Clopidogrel in Patients With Drug-Eluting Stents

Anna Maria Gori, MD*, Rossella Marcucci, MD*, Angela Migliorini, MD{dagger}, Renato Valenti, MD{dagger}, Guia Moschi, MD{dagger}, Rita Paniccia, MD*, Piergiovanni Buonamici, MD{dagger}, Gian Franco Gensini, MD*,{dagger},{ddagger}, Ruben Vergara, MD{dagger}, Rosanna Abbate, MD* and David Antoniucci, MD{dagger},*

* Department of Medical and Surgical Critical Care, University of Florence, Florence, Italy
{dagger} Department of Cardiology, Careggi Hospital, Florence, Italy
{ddagger} Center Santa Maria agli Ulivi, Don Carlo Gnocchi Foundation, Istituto di Ricovero e Cura a Carattere Scientifico, Impruneta, Florence, Italy.


Figure 1
View larger version (11K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 Kaplan-Meier Analysis

Kaplan-Meier analysis of drug-eluting stent thrombosis (A) and the composite of cardiac death and drug-eluting stent thrombosis (B) for dual responders, dual nonresponders, isolated aspirin nonresponders, and isolated clopidogrel nonresponders.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement